ExploRNA Therapeutics is pleased to announce that our Director of Business Development, Piotr Stępniak, will be attending the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Boston, taking place May 11–15, 2026.
As a leading event for advancements in cell and gene therapy, ASGCT offers an exciting platform to explore new collaborations and cutting-edge innovations. Piotr will be on-site throughout the week to connect with industry peers and discuss how ExploRNA’s proprietary mRNA technologies can enhance translation efficiency, reduce COGS, and accelerate the development of best-in-class mRNA-based therapeutics.
If you are attending, we invite you to connect with Piotr directly via the conference app, LinkedIn, or email to schedule a meeting during the event.
